287 related articles for article (PubMed ID: 7588608)
1. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.
Le Gallic L; Sgouras D; Beal G; Mavrothalassitis G
Mol Cell Biol; 1999 Jun; 19(6):4121-33. PubMed ID: 10330152
[TBL] [Abstract][Full Text] [Related]
3. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
[TBL] [Abstract][Full Text] [Related]
4. Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS.
Hester KD; Verhelle D; Escoubet-Lozach L; Luna R; Rose DW; Glass CK
Cell Cycle; 2007 Jul; 6(13):1594-604. PubMed ID: 17525531
[TBL] [Abstract][Full Text] [Related]
5. Proteins of the ETS family with transcriptional repressor activity.
Mavrothalassitis G; Ghysdael J
Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
[TBL] [Abstract][Full Text] [Related]
6. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
7. A central role for Ets-2 in the transcriptional regulation and cyclic adenosine 5'-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene.
Ghosh D; Ezashi T; Ostrowski MC; Roberts RM
Mol Endocrinol; 2003 Jan; 17(1):11-26. PubMed ID: 12511603
[TBL] [Abstract][Full Text] [Related]
8. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
9. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.
McCarthy SA; Chen D; Yang BS; Garcia Ramirez JJ; Cherwinski H; Chen XR; Klagsbrun M; Hauser CA; Ostrowski MC; McMahon M
Mol Cell Biol; 1997 May; 17(5):2401-12. PubMed ID: 9111309
[TBL] [Abstract][Full Text] [Related]
10. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of GETS-1, a goldfish Ets family member that functions as a transcriptional repressor in muscle.
Goldman D; Sapru MK; Stewart S; Plotkin J; Libermann TA; Wasylyk B; Guan K
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):267-75. PubMed ID: 9761723
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of prolactin gene transcription by the ETS-2 repressor factor.
Day RN; Liu J; Sundmark V; Kawecki M; Berry D; Elsholtz HP
J Biol Chem; 1998 Nov; 273(48):31909-15. PubMed ID: 9822660
[TBL] [Abstract][Full Text] [Related]
13. Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element.
Bidder M; Loewy AP; Latifi T; Newberry EP; Ferguson G; Willis DM; Towler DA
Biochemistry; 2000 Aug; 39(30):8917-28. PubMed ID: 10913304
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
16. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.
Albanese C; Johnson J; Watanabe G; Eklund N; Vu D; Arnold A; Pestell RG
J Biol Chem; 1995 Oct; 270(40):23589-97. PubMed ID: 7559524
[TBL] [Abstract][Full Text] [Related]
17. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
Hagman J; Grosschedl R
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
19. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
20. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.
Foulds CE; Nelson ML; Blaszczak AG; Graves BJ
Mol Cell Biol; 2004 Dec; 24(24):10954-64. PubMed ID: 15572696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
